Media Coverage

January 16, 2025

JP Morgan Healthcare Conference, Day 2: CareDx, Thermo Fisher, BillionToOne, Adaptive Biotech, More

BillionToOne CEO and Cofounder Oguzhan Atay said that the firm’s prenatal testing business is already so profitable that “we do not need any additional capital to reach cash-flow positivity with fast growth.”

Read more here.

Share this post

News & Media

BillionToOne Launches Expanded Panel for UNITY Fetal Risk Screen, Setting New Standard in Prenatal Testing

BillionToOne Expands Team with Dr.haywood Brown as Cheif Medical Officer, Prenatal

The San Francisco Business Times 40 Under 40 class of 2025

Indianapolis family aims to help expecting parents fight disease affecting tens of thousands of Americans

BillionToOne Announces Mediacare Coveage for Northstar Select

Medicare Covering BillionToOne Northstar Select Cancer Liquid Biopsy Tests